Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 7, 2017
SABRA HEALTH CARE REIT, INC.
(Exact name of registrant as specified in its charter)
|
| | | | |
Maryland | | 001-34950 | | 27-2560479 |
(State of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
|
| | |
18500 Von Karman, Suite 550 Irvine, CA | | 92612 |
(Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number including area code: (888) 393-8248
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
| |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
| |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
| |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
We are filing this Current Report on Form 8-K to amend Exhibit 23.1 (the “Original Exhibit 23.1’’) to our Annual Report on Form 10-K for the year ended December 31, 2016 filed on February 22, 2017 (the “2016 Form 10-K’’). Our independent registered public accounting firm, PricewaterhouseCoopers LLP, consented to use their reports dated February 22, 2017 that are included in the 2016 Form 10-K. In the Original Exhibit 23.1, reference to our registration statement on Form S-3 (No. 333-215574) was inadvertently omitted. The revised consent attached hereto as Exhibit 23.1 (the “Revised Exhibit 23.1’’ supersedes and replaces the Original Exhibit 23.1. The Revised Exhibit 23.1 does not change any previously reported financial results of operations or any disclosure contained in the 2016 Form 10-K.
|
| |
Item 9.01 | Financial Statements and Exhibits. |
|
| | |
| | |
(d) | | Exhibits |
23.1 | | Consent of PricewaterhouseCoopers LLP |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| | | |
| SABRA HEALTH CARE REIT, INC. |
| |
| /S/ HAROLD W. ANDREWS, JR. |
| Name: | | Harold W. Andrews, Jr. |
| Title: | | Executive Vice President, Chief Financial Officer and Secretary
|
Dated: March 7, 2017
EXHIBIT INDEX
|
| | |
Exhibit Number | | Description |
23.1 | | Consent of PricewaterhouseCoopers LLP |